Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Wright Medical Reaches Into Extremities Market With Inbone Acquisition

This article was originally published in The Gray Sheet

  • News

Executive Summary

Wright Medical plans to expand its extremity orthopedic implant offerings by acquiring total ankle replacement-maker Inbone Technologies

You may also be interested in...



Wright Buys French Extremities Device Firm For $75 Million Upfront

The acquisition of Biotech International is intended to provide Wright with a complementary extremity product portfolio and to significantly expand Wright’s direct sales channel in France and international distribution network for foot and ankle products.

BioMimetic Aims To Complete Bone Graft Study Enrollment By Year-End

BioMimetic Therapeutics is hoping enrollment in an ongoing pivotal trial for its Augment Bone Graft will be complete by year-end despite a recent slowdown in registration

BioMimetic Aims To Complete Bone Graft Study Enrollment By Year-End

BioMimetic Therapeutics is hoping enrollment in an ongoing pivotal trial for its Augment Bone Graft will be complete by year-end despite a recent slowdown in registration

Table

View full table

Related Content

Medtech Insight
Tags:
Latest Headlines

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

See All
UsernamePublicRestriction

Register

MT025898

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By